shutterstock_1644934849.jpg

CAPTARIO

bottom-right.png

Ten-Year Anniversary!

Celebrating Ten Years of Pioneering the Pharma Decision Landscape

Founded in October 2012 with a vision of revolutionizing pharma decision-making, Captario is now celebrating its tenth year as a pioneer of pharma decision optimization. No longer is our vision just a vision. Transforming the pharma industry is something that is taking place right now. We know this because we are leading the change by:
 

  • Revolutionizing pharma drug development decision-making

  • Working with the world’s largest pharma companies

  • Bringing together functional siloes in big pharma

  • Integrating development and commercial departments

 

At Captario, we aspire to be world-class in everything we do. It’s who we are. For ten years we have been pushing the limits of what is possible, and of course, this is cause for celebration! 

 

To celebrate the tenth anniversary, Captario has planned a ten-day video series of speak-easy sitdowns with various Captarians, hosted by Head of Client Solutions EU, Karl Rahn. Starting on October 12th, these chats will have different topics premiering each day until October 25th. 

 

Join us for our ten-day event, where we will showcase upcoming features of Captario SUM®, debut thought leadership, pick the brains of our fellow Captarians, and reveal some exciting news!

IMG_2475.jpg

The Spark That Ignited the Mission of Transforming a Whole Industry

Back in 2009, Captario founders Johannes Vänngård, Ingela Nylander, Mikael Palmblad, and Fredrik Celin saw that to optimize a drug development process, you must be able to integrate business functions, consider the whole product life cycle, and understand the impact of uncertainty and dependencies. When they could not find such a solution, they agreed that they would build one. The first step to founding Captario was taken.

 

Join in as host Karl Rahn starts off the ten-day celebration video series by interviewing Captario's founding team!

Book Review IG Story.png

We are truly pioneering the field of decision-making, and a big reason for that is all our Captarians! Our passion is the ever-so-valuable intangible part of our company, and we make Captario what it is today.

Anastasia Danopoulou, Senior Analyst 

One Big Idea.
One Revolutionary Solution.

The idea of Captario SUM® is simple. In reality, the mechanics of it is something revolutionary and previously not thought of within the pharma industry. 

But why is Captario SUM® so revolutionary? Why has this not been done before? And now ten years later, how is Captario transforming the ways of strategic decision-making? 

 

Join our host Karl Rahn as he once again welcomes Captario CEO, Johannes Vänngård, to the studio to talk about the idea behind Captario SUM®. 

Captario _ Symbol Only.png

Join Our Scavenger Hunt to Win a 4-Hour Workshop with Us!

To celebrate our anniversary, we of course want to include you in our celebration! To do so, we decided to do a digital scavenger hunt!

 

Somewhere on our website, we have hidden an easter egg: a very small version of our celebratory logo that you see here to the left. The rules are simple: You find it, you win! Locate the logo, click on it, and take part in the raffle to win a 4-hour workshop with us.

5.png

The people we have at this company are so smart, so intelligent, and so experienced. Just sitting in a room with them you can kind of absorb a lot of information.

Avi Garg, Senior Analyst 

Tell the True Story. 
Model More Realistically.

There is a saying at Captario that states ”If you call tell the story, we can model it.”  But what does telling the true story for your model mean?

Join our host Karl Rahn as he interviews Captario Senior Analysts Shaineze Afir and Anastasia Danopoulou about how it is possible to describe our reality in quantitative terms, why telling the true modeling story can influence the decision-making process, and how in the end it will enable success.

STUFF

Book Review IG Story.png

Every day is different, every client is different. That is the part I love about Captario. Our passion fuels the product.

Anna Sarkisyan, Senior Analyst 

IMG_2493.jpg

Predict Tomorrow.
Simulate Today.

At Captario, we emphasize that leveraging simulation and uncertainty is important. But why is it important? And what value is there in understanding uncertainty?

 

Join our host Karl Rahn as he interviews Captario Co-founder Mikael Palmblad and Senior Analyst Emma Samuelsson about how understanding uncertainty can reveal possible risks and opportunities.

15.png

The Art of
Pharma Decision-Making

At Captario, we have more than 200 years of combined experience handling and optimizing pharmaceutical decisions. For ten years, we have enlightened the pharma industry with the idea that pharma decision-making can be better.

For our tenth anniversary, we want to share that knowledge with you. In The Art of Pharma Decision-Making, you will learn firsthand how Captario thinks about making decisions for the pharmaceutical industry, what we believe you can do to extract more knowledge from your data, and what we argue are best practices when it comes to realistically replicating the conditions for a decision in a model.

Dimensional Modeling.
A New Era of Forecasting Computation.

Dive into the next big thing within pharmaceutical modeling practices. Join our host Karl Rahn as he interviews Captario's product developers, Marcus Aurén and Hampus Hallman, to talk about dimensional modeling! What is dimensional modeling? How does it work? And why is this the next step? 

Watch to learn more about the subject, hear how it will affect pharmaceutical decision-making in the future, and understand the core basics of how it works!

Book Review IG Story.png

Hampus' Idea Paves the Way for a New Generation of Modeling!

Are you intrigued by the applications of dimensional modeling and how Captario SUM® can answer your most complex questions?

If so, schedule a chat with us so we call tell you more about the perks of utilizing dimensional modeling in your modeling efforts!

IMG_2493.jpg

Dependencies Matter.
Understand the Impact.

How are your decisions connected? And how does our approach affect our decisions?

Join our host Karl Rahn as he interviews Captario Head of Analytics, Magnus Ytterstad, and Senior Analyst Emma Samuelsson, on the topic of dependencies and perspectives. Tune in as they discuss how to accurately model with dependencies and understand the value of incorporating all kinds of relationships between model entities. 

14.png

Avi Answers: What Do Simulations add to a Portfolio Forecast?

Watch Captario Analyst, Avi Garg, present a case study on why there is value in running simulations to generate a vast number of potential outcomes for a portfolio and how these highly granular analytics will help stakeholders understand the dynamic in the portfolio.

Think Holistic.
Enable Collaboration.

What does it mean to be holistic? What are the effects of having a holistic decision analysis tool?

Join our host Karl Rahn as he interviews Captario Director of Strategic Account Management, Matthew Kokkonen, to talk a little bit about how holistic approaches can be game-changing for effective decision analysis and what we can do today that we could not do before. 

Matthew Kokkonen Transparent Background.png

Matthew Ensures a Smooth Transition to Next-Level Modeling Practices!

something here.

Are You Curious About Dimensional Modeling AND Do You Like Champagne?

Are you intrigued by the applications of dimensional modeling and how Captario SUM® can answer your most complex questions?

If so, schedule a chat with us and we will send a bottle of bubbly your way so we can celebrate the anniversary together!*

* Location restrictions apply.

IMG_2493.jpg

Play the Sandbox.
Increase Your Creativity.

Is creativity important for drug development? How do you go about nurturing creativity?

Tune in together with our host Karl Rahn as he interviews Captario's Director of Strategic Account Management, Matthew Kokkonen, and head of Sales and Marketing, Brooke Duffy!

 

Together they talk about what it means to be creative in drug development and how modeling in a sandbox environment helps drug development creativity.

Captario _ Symbol Only.png

Last Chance!
Win a 4-Hour Workshop with Us!

To celebrate our anniversary, we of course want to include you in our celebration! To do so, we decided to do a digital scavenger hunt!

 

Somewhere on our website, we have hidden a very small version of our celebratory logo that you see here to the left. (Hint: It is not that one). The rules are simple: You find it, you win! Locate the logo, and take part in the raffle to win a 4-hour workshop with us.

Book Review IG Story.png

At Captario we are very comitted to our principles of integrity, transparency, and camaraderie. Even though we are located all over the world, you can still feel that we are all part of one team with a common goal.

Radwan Donval, Analyst 

5.png
IMG_2493.jpg

A Single Platform.
Multiple Applications. 

Captario SUM® is only one tool. However, we discovered that it can have many uses – uses that we previously did not intend for. 

Join our host Karl Rahn as he interviews Captario Head of Analytics, Magnus Ytterstad, and Customer Success Manager, Stephanie Mardini, on the topic of the many uses for Captario SUM®. Listen to them talk about how they apply Captario SUM® in new ways, and what exciting opportunities it allows them to work on!

Stephanie and Stig-Johan Took Inspiration From Moneyball to Analyze Digital Biomarkers!

Learn how they in collaboration with UCB applied Captario SUM® to quantify the effects of clinical trial technologies, analyze digital biomarkers, and understand how a clinical trial with a limited budget can be successful.

2.png
IMG_2493.jpg

For Pharma Excellence. 
By Pharma Experts. 

Modern medicine vitally depends upon the success of pharmaceutical drugs. What does pharmaceutical drug success mean, though?

 

In essence, it is the perfect intersection of meeting the clinical demands of patients in their time of need without wasting valuable resources. Within the pharma industry, it is well known that drug development is highly complex. The process is nuanced and requires multi-phased approaches involving research and development effectively aligned with long-term commercial planning.

Book Review IG Story.png

SUM Summit –
The First Ever Captario Conference!

Captario is hosting our own conference, entitled SUM Summit.

Come June 2023, SUM Summit will take place in Boston. More news to come.

Captario – A Story of Revolutionizing Pharma Decision-Making

Founded in 2012 with a vision of revolutionizing pharma decision-making, Captario is celebrating its 10th year as a game-changer in the pharma industry.

But how did Captario end up as the company it is today? Here is a quick recap of how Captario came to be the future of pharma decision-making.

Insight

It was back in 2009 that the first initial idea of a tailored, holistic project decision tool came to life. A group of people working at AstraZeneca saw that the way they were currently conducting forecasting analyses and extracting data from their drug development processes was not as good as they would have hoped. To optimize the process of making good project decisions, they learned you must be able to:

  • Integrate business functions

  • Consider the product life cycle

  • Understand the impact of uncertainty, dependencies, and correlation
     

They realized that there had to be a better solution and started experimenting. When they could not find one that met their desired scope, they agreed that they would build one. The first step to founding Captario was taken.
 

The Founding

In October 2012, Captario was founded by Johannes Vänngård, Ingela Nylander, Mikael Palmblad, and Fredrik Celin, with its first office in the basement of Johannes’s home. The goal was clear - transform pharma decision-making. But how?

Agreeing on which path to take to was not an easy task, although heated arguments can be a way to find the right path forward. Eventually, there was consensus about some pillars this new revolutionizing decision support system was going to stand on. These were:
 

  • Holistic end-to-end models of drug projects

  • Embracing uncertainty – represented by the assumptions being input to the models

  • Using BPMN to provide a process map of the project

  • Leveraging Monte Carlo Simulation to enable analyses of decision alternatives
     

The first steps to creating Captario SUM® (Strategic Uncertainty Management) were taken.
 

Laughing Investors

In 2015, Captario had run out of money and was looking for investments. But who would back a small Swedish company that set out to revolutionize the pharmaceutical industry? Going into pitch meetings with multiple investment firms, few believed that Captario would be able to transform the way the pharma industry makes decisions. The Captario vision of selling to the world’s largest pharma companies, bringing together functional siloes in big pharma, integrating development and commercial departments, and having all data in the cloud, did not resonate with investors. More so, they laughed at the idea.

Eventually, Captario found investors that shared the Captario vision. The best laugh is the last. The journey to transforming the pharma industry continued.
 

First Customer

The same year, 2015, Captario contracted its first customer. The customer experienced the difficulties and problems that Captario was intent on solving, and the customer was willing to try a pilot with Captario SUM® with their motto; ”Today’s struggle can be tomorrow’s key asset.”
 

The customer threw its most complex projects at Captario, resulting in many hours to handle the workload and prove the value of Captario SUM®. This was the first chance to really test the system and the simulation engine. At the time, simulating one asset with 10,000 iterations took approximately 1.5 hours. Still, Captario attracted the attention of a senior leader who took an interest in what Captario was doing.  The following year, the customer agreed to present the pilot study on behalf of Captario at a conference, demonstrating the computational power they could leverage using Captario SUM®, and how that had impacted their portfolio.

With a first customer and a tangible product in place, the future was looking bright.
 

Expanding Focus

In 2021, Captario actively decided to level up its current operations. Having both lost and won new customers during a six-year period, it was time to push harder for the industry. With that, the board decided on a high-level strategy leading to a heavy expansion across departments. That included an extra focus on expanding a customer success team, sales and marketing, and hiring more developers to support the technical development of Captario SUM®. The inspiration was simple: “Full attention to customer needs, cooperation, taking responsibility, and going the extra mile will create success.”

The strategy further included assisting all customers not only with a state-of-the-art strategic decision-making tool but also include the launch of Professional Services. This would enable more customers to experience the power of Captario SUM®.

The new strategy quickly paid off. Going into the summer of 2021, Captario had already lined up four new interested clients. When summer had passed, all 4 opportunities had been won. They had all seen the value of Captario SUM®.

 

Next Steps

In 2022, 10 years after its founding, Captario entered a new phase. No longer is the vision of transforming the pharma industry just a vision. It is something that is taking place. We know this because clients are paying for it. All the goals that were set have been realized. We are:
 

  • Revolutionizing pharma drug development decision-making

  • Working with the world’s largest pharma companies

  • Bringing together functional siloes in big pharma

  • Integrating development and commercial departments

  • Managing this data in the cloud
     

Looking back, simulating one asset with 10,000 iterations took approximately 1.5 hours. Today, Captario SUM® can simulate 100,000 iterations in the blink of an eye. We know that the better we do, the better our customers can do, and in the end, the better the global society can do.

At Captario, we aspire to be world-class in everything we do. It is who we are. We will never stop pushing the limits of what is possible. That is how Captario makes a difference.

We are the change.

 

4.png

Captario is rewriting the rules of what it means to make strategic decisions. I am so proud of our talented team, and it feels even more exciting that this is only the beginning of what Captario can do. 

Johannes Vänngård, CEO & Co-founder